Authors: Candido, KA Shimizu, K McLaughlin, JC Kunkel, R Fuller, JA Redman, BG Thomas, EK Nickoloff, BJ Mule, JJ

Citation: Ka. Candido et al., Local administration of dendritic cells inhibits established breast tumor growth: Implications for apoptosis-inducing agents, CANCER RES, 61(1), 2001, pp. 228-236

Authors: Shimizu, K Fields, RC Redman, BG Giedlin, M Mule, JJ

Citation: K. Shimizu et al., Potentiation of immunologic responsiveness to dendritic cell-based tumor vaccines by recombinant interleukin-2, CA J SCI AM, 6, 2000, pp. S67-S75

Authors: Brewer, GJ Dick, RD Grover, DK LeClaire, V Tseng, M Wicha, M Pienta, K Redman, BG Jahan, T Sondak, VK Strawderman, M LeCarpentier, G Merajver, SD

Citation: Gj. Brewer et al., Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study, CLIN CANC R, 6(1), 2000, pp. 1-10

Authors: Small, EJ Lew, D Redman, BG Petrylak, DP Hammond, N Gross, HM Eastham, JA Crawford, ED

Citation: Ej. Small et al., Southwest oncology group study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: The importance of survival as a clinical trialend point, J CL ONCOL, 18(13), 2000, pp. 2537-2544

Authors: Redman, BG Chang, AE

Citation: Bg. Redman et Ae. Chang, Immunotherapy in renal cell carcinoma - The Bukowski article reviewed, ONCOLOGY-NY, 13(6), 1999, pp. 810

Authors: Esper, P Redman, BG

Citation: P. Esper et Bg. Redman, Supportive care, pain management, and quality of life in advanced prostatecancer, UROL CLIN N, 26(2), 1999, pp. 375